UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer, ISSN 0008-543X, 02/2013, Volume 119, Issue 3, pp. 629 - 638
lymphoma, Surveillance | marginal zone B-cell lymphoma | program, epidemiology | Epidemiology | mucosa-associated lymphoid tissue (MALT) | End Results (SEER) | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Data Interpretation, Statistical | Humans | Middle Aged | Databases, Factual - statistics & numerical data | Lymphoma, B-Cell, Marginal Zone - epidemiology | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Splenic Neoplasms - mortality | Young Adult | Lymphoma, B-Cell, Marginal Zone - ethnology | Splenic Neoplasms - epidemiology | Splenic Neoplasms - pathology | Survival Analysis | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Aged | SEER Program - statistics & numerical data | Neoplasm Staging | Continental Population Groups - statistics & numerical data | Causes of | Care and treatment | Lymphomas | Prognosis | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 17, pp. 2072 - 2081
Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Humans | Receptor, Notch2 - genetics | Hepatitis C, Chronic - complications | Autoimmune Diseases - etiology | Splenectomy | Cell Transformation, Neoplastic - genetics | Paraneoplastic Syndromes - immunology | Neoplasm Proteins - genetics | Splenic Neoplasms - drug therapy | Diagnosis, Differential | Antiviral Agents - therapeutic use | Splenic Neoplasms - genetics | Lymphoma, B-Cell, Marginal Zone - epidemiology | Combined Modality Therapy | Splenic Neoplasms - diagnosis | Hepatitis C, Chronic - drug therapy | Paraneoplastic Syndromes - etiology | Lymphoma, B-Cell, Marginal Zone - genetics | Lymphoma, B-Cell, Marginal Zone - diagnosis | Splenic Neoplasms - epidemiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Watchful Waiting | Disease Management | Mutation | Kruppel-Like Transcription Factors - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 2013, Volume 24, Issue 6, pp. vi144 - vi148
Life Sciences & Biomedicine | Oncology | Science & Technology | Stomach Neoplasms - diagnosis | Follow-Up Studies | Risk Assessment | Humans | Helicobacter pylori - pathogenicity | Lymphoma, B-Cell, Marginal Zone - epidemiology | Stomach Neoplasms - therapy | Europe - epidemiology | Lymphoma, B-Cell, Marginal Zone - therapy | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Antineoplastic Agents - therapeutic use | Lymphoma, Non-Hodgkin - epidemiology | Anti-Bacterial Agents - therapeutic use | Lymphoid Tissue - pathology | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, Non-Hodgkin - therapy | Helicobacter Infections - drug therapy | Stomach Neoplasms - epidemiology | Neoplasm Staging | Lymphoma, Non-Hodgkin - diagnosis | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 17, pp. 2064 - 2071
Life Sciences & Biomedicine | Hematology | Science & Technology | Lymph Nodes - pathology | Prognosis | Humans | Transcriptome | Lymphoma, B-Cell, Marginal Zone - therapy | Neoplasm Proteins - antagonists & inhibitors | Hepatitis C, Chronic - complications | Molecular Targeted Therapy | Immunotherapy | Adult | Lymphoma, B-Cell, Marginal Zone - pathology | Neoplasm Proteins - genetics | Genetic Association Studies | Antiviral Agents - therapeutic use | Lymphoma, B-Cell, Marginal Zone - epidemiology | Treatment Outcome | Combined Modality Therapy | Hepatitis C, Chronic - drug therapy | Radiotherapy | Disease Progression | Lymphoma, B-Cell, Marginal Zone - genetics | Genes, Immunoglobulin | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Disease Management | Index Medicus | Abridged Index Medicus
Journal Article
Journal of gastroenterology and hepatology, ISSN 0815-9319, 09/2016, Volume 31, Issue 9, pp. 1572 - 1583
marginal zone B‐cell lymphoma | gastroscopy | non‐Hodgkin lymphoma | stomach neoplasm | Helicobacter pylori | non-Hodgkin lymphoma | marginal zone B-cell lymphoma | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Age Distribution | Prevalence | Prognosis | Early Detection of Cancer - methods | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Helicobacter Infections - complications | Male | Helicobacter Infections - therapy | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Adult | Female | Stomach Neoplasms - epidemiology | Retrospective Studies | Republic of Korea - epidemiology | Lymphoma, B-Cell, Marginal Zone - microbiology | Stomach Neoplasms - diagnosis | Helicobacter Infections - epidemiology | Kaplan-Meier Estimate | Lymphoma, B-Cell, Marginal Zone - epidemiology | Stomach Neoplasms - therapy | Treatment Outcome | Gastroscopy | Lymphoma, Large B-Cell, Diffuse - microbiology | Stomach Neoplasms - microbiology | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, Large B-Cell, Diffuse - epidemiology | Sex Distribution | Aged | Cohort Studies | Lymphomas | Clinics | Diagnosis | Endoscopy | Stomach cancer | Cancer | Index Medicus
Journal Article
JAMA dermatology (Chicago, Ill.), ISSN 2168-6068, 02/2014, Volume 150, Issue 4, pp. 412 - 418
Life Sciences & Biomedicine | Dermatology | Science & Technology | Autoimmunity | Gastrointestinal Diseases - epidemiology | Humans | Middle Aged | Male | Skin Neoplasms - blood | Case-Control Studies | Incidence | Young Adult | Helicobacter pylori | Hashimoto Disease - epidemiology | Antibodies, Antinuclear - blood | Sjogren's Syndrome - epidemiology | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Surveys and Questionnaires | Lymphoma, B-Cell, Marginal Zone - blood | Skin Neoplasms - pathology | Comorbidity | Lupus Erythematosus, Systemic - epidemiology | Helicobacter Infections - epidemiology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Skin Neoplasms - epidemiology | Adolescent | Aged | Neoplasms - epidemiology | Dermatomycoses | Complications and side effects | Gastrointestinal diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Surgery, ISSN 0039-6060, 2009, Volume 146, Issue 6, pp. 1105 - 1115
Surgery | Life Sciences & Biomedicine | Science & Technology | Multivariate Analysis | United States - epidemiology | Prognosis | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Male | Lymphoma - mortality | Lymphoma, B-Cell, Marginal Zone - mortality | Lymphoma, Non-Hodgkin - pathology | Lymphoma, Follicular - epidemiology | Aged, 80 and over | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Lymphoma - epidemiology | Thyroid Neoplasms - mortality | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Kaplan-Meier Estimate | Lymphoma, B-Cell, Marginal Zone - epidemiology | Lymphoma, Follicular - mortality | Lymphoma, Non-Hodgkin - epidemiology | Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - epidemiology | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Non-Hodgkin - mortality | Neoplasm Staging | Thyroid Neoplasms - pathology | Medical colleges | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Immunohistochemistry | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Burkitt Lymphoma - epidemiology | Incidence | Burkitt Lymphoma - pathology | Lymphoma, Follicular - epidemiology | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma - therapy | Neoplasm Invasiveness - pathology | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Databases, Factual | Burkitt Lymphoma - therapy | Lymphoma - epidemiology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Disease-Free Survival | Conjunctival Neoplasms - epidemiology | Internationality | Lymphoma, Large B-Cell, Diffuse - epidemiology | Survival Analysis | Aged | Biopsy, Needle | Neoplasm Staging | Index Medicus | Abridged Index Medicus
Journal Article
Best practice & research. Clinical haematology, ISSN 1521-6926, 2016, Volume 30, Issue 1-2, pp. 84 - 91
Hematology, Oncology and Palliative Medicine | Epidemiology | Environmental | Marginal zone lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Environmental Exposure - adverse effects | Helicobacter pylori - immunology | Humans | Middle Aged | Age of Onset | Helicobacter Infections - epidemiology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Lymphoma, B-Cell, Marginal Zone - immunology | Aged | Helicobacter Infections - immunology | Lymphoma, B-Cell, Marginal Zone - microbiology | Environmental aspects | Medicine, Experimental | Medical research | Lymphomas | Index Medicus
Journal Article
Future oncology (London, England), ISSN 1479-6694, 05/2018, Volume 14, Issue 12, pp. 1213 - 1222
lymphoma | MALT | marginal zone lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Splenic Neoplasms - drug therapy | Splenic Neoplasms - immunology | Lymph Nodes - pathology | Neoplasm Recurrence, Local - prevention & control | Humans | Lymphoma, B-Cell, Marginal Zone - epidemiology | Lymphoma, B-Cell, Marginal Zone - immunology | Drug Resistance, Neoplasm | Treatment Outcome | Antineoplastic Agents - therapeutic use | Receptors, Antigen, B-Cell - antagonists & inhibitors | Receptors, Antigen, B-Cell - metabolism | Receptors, Antigen, B-Cell - immunology | Signal Transduction - immunology | Splenic Neoplasms